Increased Synthetic Cytotoxicity of Combinatorial Chemoradiation Therapy in Homologous Recombination Deficient Tumors

Authors:

Abstract
No abstract available
Funding Information
  • AstraZeneca
  • National Cancer Institute (P50CA247749)
  • National Cancer Institute (P30 CA008)
  • Merck
  • National Institutes of Health

This publication has 50 references indexed in Scilit: